ArticleJournal for immunotherapy of cancer2024

Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy.

Donghwan Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.